Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer: A retrospective analysis.
H. Prenen
No relevant relationships to disclose
R. Geva
No relevant relationships to disclose
H. Piessevaux
No relevant relationships to disclose
S. Tejpar
Honoraria - Merck Serono
Research Funding - Merck Serono
C. Verslype
No relevant relationships to disclose
J. Vannoote
No relevant relationships to disclose
L. Mortier
No relevant relationships to disclose
E. Van Cutsem
Consultant or Advisory Role - Roche
Research Funding - Roche